PineBridge Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-1,390
Closed -$38K – 740
2020
Q1
$38K Sell
1,390
-63,842
-98% -$1.91M ﹤0.01% 582
2019
Q4
$1.91M Sell
65,232
-15,802
-20% -$376K 0.03% 381
2019
Q3
$1.55M Buy
81,034
+6,608
+9% +$155K 0.03% 532
2019
Q2
$1.63M Buy
74,426
+54,015
+265% +$1.19M 0.03% 430
2019
Q1
$417K Buy
+20,411
New +$355K 0.01% 732

Other funds holding NEO

PineBridge Investments's NEO Position: Q2 2020 in Review

PineBridge Investments sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 1,390 shares — an estimated $38K sold.

PineBridge Investments first reported a position in NEO in Q1 2019 and held it in 5 quarters. The position peaked at $1.91M in Q4 2019. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

  • PineBridge Investments reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
  • PineBridge Investments sold 1,390 NeoGenomics shares in Q2 2020, an estimated $38K.
  • PineBridge Investments first reported a position in NeoGenomics in Q1 2019 and held it in 5 quarters.
  • PineBridge Investments's NeoGenomics position peaked at $1.91M in Q4 2019.
  • 285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on PineBridge Investments's 13F filing for Q2 2020, filed 13 Aug 2020.